Vasodilators for primary Raynaud's phenomenon-Reference-Cited by-同舟云学术

Vasodilators for primary Raynaud's phenomenon

Published:2021-05-17 Issue:5 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Su Kevin YC¹,Sharma Meghna¹²,Kim Hyunjun Jonathan¹,Kaganov Elizabeth¹²,Hughes Ian³⁴,Abdeen Mohamed Hashim¹,Ng Jennifer Hwee Kwoon¹⁵

Affiliation:

1. Department of Rheumatology; Gold Coast University Hospital; Southport Australia

2. School of Medicine; Bond University; Robina Australia

3. Office for Research Governance and Development; Gold Coast University Hospital; Southport Australia

4. School of Medicine, The University of Queensland; St Lucia Australia

5. School of Medicine; Griffith University, Gold Coast Campus; Southport Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference126 articles.

1. Vardenafil for the treatment of Raynaud phenomenon: a randomized, double-blind, placebo-controlled crossover study;Caglayan;Archives of Internal Medicine,2012

2. Clinical and physiological assessment of angiotensin-converting enzyme inhibition in primary Raynaud's phenomenon;Challenor;British Journal of Clinical Pharmacology,1989

3. Subjective and objective assessment of enalapril in primary Raynaud's phenomenon;Challenor;British Journal of Clinical Pharmacology,1991

4. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial;Chung;Arthritis and Rheumatism,2009

5. Phase III study of topical gel for treatment and prevention of Raynaud's phenomenon clinicaltrials.gov/show/NCT00266669

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenomeen van Raynaud;Kleine Kwalen in de huisartsenpraktijk;2023-11-14

2. ADRA2A and IRX1 are putative risk genes for Raynaud’s phenomenon;Nature Communications;2023-10-12

3. Cold Hands or Feet;Medical Clinics of North America;2023-09

4. A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions;Pharmaceuticals;2023-04-10

5. Inositol in Dermatologic Diseases;MED BALEAR;2023